Profound Medical PROF Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 71.1%+0.3pp | 70.8%-1.7pp | 72.5%+3.1pp | 69.4%+1.8pp | 67.6%+1.8pp | |
| Operating margin | -202.6%+53.7pp | -256.3%+39.1pp | -295.4%+62.0pp | -357.4%-50.9pp | -306.4%+3.1pp | |
| Net margin | -206.8%+57.7pp | -264.4%+10.7pp | -275.2%+68.8pp | -344%-74.6pp | -269.4%-8.9pp | |
| Returns | ||||||
| Return on equity | -70.6%-3.5pp | -67.1%+58.1pp | -125.2%-20.9pp | -104.2%-37.9pp | -66.4%-5.7pp | |
| Return on invested capital | -295.1%+79.1pp | -374.1%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.3×+0.1× | 0.2×— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 6.6×-6.0× | 12.5×+8.3× | 4.2×-4.3× | 8.5×-2.8× | 11.3×+0.8× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×+0.1× | 0.1×-0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $1.64-25.5% | $2.20+106% | $1.07-18.3% | $1.31-22.7% | $1.69-30.7% | |
| Valuation | ||||||
| Market capitalization | $241.65M+30.7% | $278.37M+89.4% | $146.96M-21.1% | $186.33M+6.6% | $174.83M-22.5% | |
| Price / sales | 12.8×-2.8× | 17.3×+7.0× | 10.3×-5.5× | 15.7×+1.0× | 14.7×-6.4× | |
| Price / book | 4.1×-0.6× | 4.2×-0.4× | 4.6×-0.2× | 4.7×+1.3× | 3.4×-0.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Profound Medical's profit margins?
- Profound Medical (PROF) runs a 71.1% gross margin and a -202.6% operating margin, with a -206.8% net margin.
- Where do Profound Medical's ratios come from?
- Every ratio is computed from Profound Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
